PATENT CLAIM ANALYSIS

Application Number: 16173114
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["424", "136100"]

Abstract:
Multispecific proteins that bind and specifically redirect NK cells to lyse a target cell of interest are provided without non-specific activation of NK cells in absence of target cells. The proteins have utility in the treatment of disease, notably cancer or infectious disease.

Claim (Index 107):
A method of producing a multispecific antigen binding protein according to  claim 79  comprising culturing a cell according which comprises a nucleic acid or nucleic acids which separately or in combination encodes for the expression of said multispecific antigen binding protein wherein culturing is under conditions whereby said multispecific antigen binding protein is expressed by the cell.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 97.0
- Lexical Diversity: 1.31429
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15190337', '15321650', '14691509', '16041309', '11921123']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7897204431535615
- 35 USC 102 Novelty (BERT): 0.6450199327955229
- Combined Prediction Score: 0.7752503921177577
- Mean Citation Score: 535.968584
- Max Citation Score: 918.7742
- Similarity Product: 568.1449179897667

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test